Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 4Head & Neck 3Breast 3Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1Other 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Stomach Ulcer 1Stomach Neoplasms 1Li-Fraumeni Syndrome 1Hamartoma Syndrome, Multiple 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastritis 1Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Physical Examination × Gastrointestinal × Clear all
NCT06848400 2025-07-09

Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios

Nanfang Hospital, Southern Medical University

Phase NA Recruiting
482 enrolled
Gastrointestinal

Gastritis, Gastrointestinal Diseases, Gastrointestinal Hemorrhage, Stomach Neoplasms, Stomach Ulcer

NCT06712095 2024-12-05

PILLCAM

Royal Marsden NHS Foundation Trust

Phase NA Recruiting
25 enrolled
Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis, Hamartoma Syndrome, Multiple, Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡